MCT INHIBITION SYNERGIZES WITH TYROSINE KINASE AND MTOR INHIBITOR TREATMENT IN RENAL CELL CARCINOMA

被引：0
|
作者：
Jambunathan, Bhaghyasree
Dergham, Abdo
Bhattacharjee, Sayani
Wynn, Rebecca
Sindhwani, Puneet
Petros, Firas
Nadiminty, Nagalakshmi
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD43-03
引用
收藏
页码：E702 / E702
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF RENAL CARCINOMA IN A BINTURONG (ARCTICTIS BINTURONG) WITH NEPHRECTOMY AND A TYROSINE KINASE INHIBITOR
    Thompson, Kimberly A.
    Patterson, Jon
    Fitzgerald, Scott D.
    Needle, David
    Harrison, Tara
    JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2016, 47 (04) : 1109 - 1113
  • [22] Pazopanib: An Oral Multitargeted Tyrosine Kinase Inhibitor for Use in Renal Cell Carcinoma
    LaPlant, Kourtney D.
    Louzon, Paige D.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (06) : 1054 - 1060
  • [23] mTOR pathway inhibition in renal cell carcinoma
    Pinto Marin, Alvaro
    Redondo Sanchez, Andres
    Espinosa Arranz, Enrique
    Zamora Aunon, Pilar
    Castelo Fernandez, Beatriz
    Gonzalez Baron, Manuel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 356 - 361
  • [24] Adjuvant therapy in renal cell carcinoma: Tyrosine kinase inhibitor versus immune checkpoint inhibitor
    Zhou, Qingbo
    Liu, Jianjiang
    Xie, Shaoqin
    MEDICINE, 2024, 103 (22) : E38329
  • [25] Combined inhibition of autophagy with mTOR inhibitor to enhance cell death in renal cell carcinoma.
    Chen, Hua
    Potts, Kyle
    Murray, Allan
    Hitt, Mary
    Moore, Ron
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [26] Tyrosine kinase inhibitor sunitinib targets the vasculature of clear cell renal cell carcinoma: a morphometrical study of treatment effect
    Chen, Lu
    Chen, Longwen
    Huang, Jie
    Xu, Danfeng
    Wang, Linhui
    Zhou, Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (03): : 3571 - 3578
  • [27] Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinoma
    Reed, Jarred P.
    Posadas, Edwin M.
    Figlin, Robert A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (03) : 259 - 271
  • [28] Tyrosine kinase inhibitors in renal cell carcinoma
    Potti, A
    George, DJ
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6371S - 6376S
  • [29] Ongoing Screening and Treatment to Potentially Reduce Tyrosine Kinase Inhibitor-Related Fatigue in Renal Cell Carcinoma
    Anand, Deepa
    Escalante, Carmen P.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 50 (01) : 108 - 117
  • [30] Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report
    Azuma, Takeshi
    Sugihara, Tohru
    Honda, Sachi
    Yoshizaki, Uran
    Nimi, Fusako
    Tsuru, Ibuki
    Kume, Haruki
    ONCOLOGY LETTERS, 2019, 17 (04) : 4011 - 4015
12345